Medical Bionic Implant/Artificial Organs Market Size was valued at USD 13.45 Billion in 2023. The Medical Bionic Implant/Artificial Organs industry is projected to grow from USD 17.65 Billion in 2024 to USD 24.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.65% during the forecast period (2024 - 2032). Artificial organs and implants are types of special devices made to carry out the implantation of organs in the human body. It is mainly used so that the organs can function or intimate the original organ. Bionics is divided into parts and are biology and electronics. Medical bionics are substituted robotic versions of the body parts that are damaged.
Organ transplants become necessary when an organ of a body gets damaged due to any reason. However, there are also chances that the brogan transplant will not succeed as sometimes the body rejects the organ transplant. It is a substance introduced in the body to improve the body and make it function like before. The most developed bionics organs, heart and kidney and the most developed medical bionics, are pacemaker and cochlear.
At present, the market is influenced by the increasing demand for organ transplantation among patients. Nevertheless, the feasibility of transplantation is limited because to the scarcity of donors in comparison to the number of patients in need. The market expansion is bolstered by the continuous innovation in technology within the healthcare industry, particularly in the areas of equipment, treatment, and diagnostics. Ther is a growing public awareness regarding various ailments and their corresponding treatments, and the progress in the field of Artificial Organs industry procedures is playing a significant role in attracting attention to this industry.
The growth of the Medical Bionic Implant/Artificial Organs Market is further stimulated by advancements in 3D printing technology. The industry is seeing significant expansion due to the rising incidence of accidents resulting in organ damage and subsequent organ transplantation. The market expansion of eye illnesses within the context of a regulatory framework is likewise seeing an upward trend. The market expansion is being driven by the increasing prevalence of organ failure, which is mostly attributed to age-related diseases and aging factors. The Medical Bionic Implant Market Share is seeing accelerated growth due to rapid technical advancements and government efforts in the healthcare sector, creating a promising new potential. The increasing awareness among individuals regarding their health and the regularity with which they seek medical check-ups have also resulted in significant business opportunities.
In April 2023, Pixium Vision, a startup focused on addressing visual impairment through the implementation of bionic implants, potentially received an expedited regulatory pathway from the U.S. Food and Drug Administration (FDA). The Prima system, developed by a French company, has been granted a breakthrough designation. Its primary objective is to address the issue of deteriorating light receptors located at the posterior part of the eye in those suffering from dry age-related macular degeneration (AMD). The primary objective of the Prima system is to partially reinstate visual acuity within the central region of an individual's visual field, which is the area most impacted by the aforementioned ailment, while simultaneously preserving the normal functionality of their peripheral vision. The system comprises of a wireless retinal implant of around two millimeters in size, accompanied by a camera affixed to a pair of spectacles, which is coupled to a compact processing device that can be conveniently carried in a pocket.
Pixium Vision, a firm specializing in bionic implants to treat visual impairment, may have been granted an accelerated regulatory pathway by the U.S. Food and Drug Administration (FDA) in April 2023. The Prima system, created by a French business, has received a breakthrough designation. The main goal is to tackle the problem of declining light receptors at the back of the eye in individuals with dry age-related macular degeneration (AMD). The main goal of the Prima system is to restore some level of vision in the central area of a person's visual field, which is primarily affected by the described condition, while still maintaining the normal functioning of their peripheral vision. The technology consists of a small wireless retinal implant of approximately two millimeters. It is accompanied by a camera attached to a pair of glasses, which is connected to a compact processing equipment that can be easily carried in a pocket.
In December 2022, VanEck launched the first-ever exchange-traded fund (ETF) in Europe that exclusively targets companies involved in bionic engineering within the healthcare industry. The primary holdings of the ETF include Dexcom, a business involved in the manufacturing of glucose monitoring implants, Stryker, a producer of orthopaedic and neurotechnology implants, and Edwards Lifesciences, a specialist in artificial heart valves. As technology progresses, it is expected that there will be an increased focus on developing apps that specifically target the functions of the brain and nervous systems. VanEck has recently launched CYBO as its second product specifically targeting the healthcare sector.
Covid-19 analysis
Pandemic affected most of the business, but the healthcare sector gained growth. The Healthcare sector is the one sector that improved its marketplace. Due to the virus spread, people got dependent on the healthcare sector for treatment, which positively impacted the market. But due to the constant attention to the covid patients, other patients got ignored and didn't get the required treatment which is a major issue for the market growth. When the manufacturers and production facilities were ordered to closed and people were told to stay inside to lessen the spread, the shutdown of markets and quarantine orders by the government impacted the market negatively.
Chief Factors Existing In The Market
Currently, the market is driven by the rising number of patients in need of organ transplantation. However, the transplant is not possible for everyone as the number of donors is very less than the number of patients. Continuous advancement in technology in the healthcare sector like equipment, treatment, and diagnosis boosts the market growth. The public is getting aware of several diseases and treatments, and advancement in the Artificial Organs Market procedure is helping the market to gain the highlight. The development of 3D printers in the Medical Bionic Implant/Artificial Organs Market also propels the market to grow in the forecast period. The increasing cases of accidents that lead to organ damage and organ transplant are the major growth factor for the market. The growing eye diseases with regulatory framework is also gaining market growth. Due to age-related issues and aging factors, people are experiencing organ failure enhancing the market growth.
The less number of donors and growing number of transplant patients is a huge challenge for the market to overcome. Although the number of patients increases, the advanced technology has still not made each transplant successful, due to which the Medical Bionic Implant/Artificial Organs Market is still facing several obstacles.
Rapid technological advancement and government initiatives for healthcare are accelerating the market, forming a new opportunity for the Medical Bionic Implant Market Share. People getting more aware of their health and getting them check-ups once in a while also creates ample opportunity for the market.
The drivers are accelerating the market, but with the acceleration, several factors are also restraining the market from further growth. The drawbacks of holding the market are the high cost of the devices no certain reimbursement. The development cost is high, and with that, fewer experts doctors for such challenging roles is less, which is also negatively affecting the market growth.
Cumulative Evaluation Of The Market
The cumulative evaluation of the market shows various research done in the Medical Bionic Implant/Artificial Organs Market to develop the overall marketplace. Different segments like drivers and opportunities are accelerating the market and forming new ways for the new key players who are keen to invest in it. However, the key players must know about the restraints and challenges of the market to tackle them and try to overcome them as soon as possible to register a high growth rate in the forecast period. The impact of COVID is also mentioned in the evaluation of the Medical Bionic Implant Market Outlook to give the market a new form and depict that the market will grow further in the future.
The market is bifurcated into Mechanical and Electronic Bionics based on the technology segment. Both segments make the market grow and contribute to the Medical Bionic Implant Market Value.
Based on the segment product, the Medical Bionic Implant/Artificial Organs Market is classified into Vision, Ear, Orthopedic, Heart, Neural/Brain. The Vision bionics has further been divided into the bionic eye. The bionic ear segment is classified into the cochlear implant and bone-anchored hearing aid. Orthopedic bionics are segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. Sub-segments of the bionic leg include bionic knees and bionic feet. Electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are segmented into pacemakers, total artificial heart, ventricular assist device, an artificial heart valve. The pacemaker has an implantable cardiac pacemaker and an external pacemaker. The sub-segments of the artificial heart valve include the mechanical heart valve and tissue heart valve. Neural/brain bionics of the market are divided into deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators and improve the Medical Bionic Implant Market Size.
The fixation of the Medical Bionic Implant/Artificial Organs Market is segregated into Implantable and Externally Worn. Each segment variable is pushing the market forward and making the market grow to get a place in the global marketplace.
The medical bionic implant/artificial organs market is segmented into hospitals and clinics, research and academic institutes, and others.
In December 2022, VanEck introduced the inaugural exchange-traded fund (ETF) in Europe that specifically focuses on firms engaged in the field of bionic engineering within the healthcare sector. The main allocations of the ETF consist of Dexcom, a company engaged in the production of glucose monitoring implants, Stryker, a manufacturer of orthopaedic and neurotechnology implants, and Edwards Lifesciences, a specialist in artificial heart valves. With the advancement of technology, it is anticipated that there would be a heightened prominence of applications centered around the functionalities of the brain and nervous systems. VanEck has just introduced CYBO as its second offering aimed at the healthcare industry.
Regional analysis
The Medical Bionic Implant/Artificial Organs Market is studied in America, Asia, Pacific, Europe, the Middle East, Africa, and other parts. America is experiencing a high growth rate due to the presence of major key players and the introduction of advanced medical bionic equipment. Europe is dominating the market in the second place owing to the government's support in the region towards the development of the region and expenditure for research. Also, due to the rising cases of organ failures and other complications. Due to the increasing number of patients, rising demand for advanced treatment, healthcare sector development, growth in healthcare in the various Asian region is increasing, which directly accelerates the market growth. The Middle East and Africa are not showing the required growth as the region lacks technical knowledge and is not developing. Due to the poor medical facilities in the region, the market is lacking growth region. Other regions are showcasing significant growth and are expected to increase the CAGr of the market. The Medical Bionic Implant Market Analysis shows the market's growth in different regions.
Competitive Intensity Within The Industry
Several key players are investing in the Medical Bionic Implant/Artificial Organs Market is expecting the market to grow in the forecast period. The Market development is based on the strategies don by the prominent players for market growth. The report consists of several details about the competitor. Other than that, that are many more details depicted in the report by the competitors are market production, market dominance, finance, investment, profit, and others. The key players are expected to improve the market value with several techniques. The competitive intensity between the prominent market investors will have a positive impact. The major key payers those are Medical Bionic Implant Market Growth are
Recent development
Report Overview
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â 24.56 Billion |
| Â Â CAGR | Â 9.65% (2024-2032) |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2021 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Technology, Product, Fixation, and End-user |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.). |
| Â Â Key Market Opportunities | Â Â New product launches and R&D Amongst major key Players |
|   Key Market Drivers | · Technological advancements· Increasing accidents and injuries· Improving regulatory framework· Increasing government assistance Increasing prevalence of eye diseases |
Medical Bionic Implant Artificial Organs Market Highlights:
Frequently Asked Questions (FAQ) :
Medical Bionic Implant/Artificial Organs Market is projected to grow at a 9.65% CAGR between 2024-2032.
The Americas is expected to lead the Medical Bionic Implant/Artificial Organs Market.
Improving regulatory framework and increasing injuries and accidents are adding market growth.
High cost and poor healthcare system may limit market growth.
Different strategies used by market players to create a dominance in the Medical Bionic Implant/Artificial Organs Market include mergers and acquisitions, collaborations, product launches, and strategic alliances.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
